These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 10972597
1. Phosphodiesterase inhibitors: the inotropes of choice for the new millennium? Levy JH, Bailey JM. J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):365-6. PubMed ID: 10972597 [No Abstract] [Full Text] [Related]
3. Use of inotropes in the critical care setting. Löllgen H, Drexler H. Crit Care Med; 1990 Jan; 18(1 Pt 2):S56-60. PubMed ID: 2136722 [Abstract] [Full Text] [Related]
4. New positive inotropic agents in the treatment of left ventricular dysfunction. De Luca L, Proietti P, Palombaro GL, Battagliese A, Celotto A, Bucciarelli Ducci C, Fedele F. Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917 [Abstract] [Full Text] [Related]
5. Milrinone, not epinephrine, improves left ventricular compliance after cardiopulmonary bypass. Lobato EB, Gravenstein N, Martin TD. J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):374-7. PubMed ID: 10972599 [Abstract] [Full Text] [Related]
6. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index. Yamada T, Takeda J, Katori N, Tsuzaki K, Ochiai R. J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598 [Abstract] [Full Text] [Related]
7. Drugs recently released in Belgium. Milrinone--ondansetron. Harvengt C. Acta Clin Belg; 1991 Aug; 46(1):56-60. PubMed ID: 1645919 [No Abstract] [Full Text] [Related]
8. French multicentre survey on the use of inotropes after cardiac surgery. Bastien O, Vallet B, French Study Group AGIR. Crit Care; 2005 Jun; 9(3):241-2. PubMed ID: 15987409 [Abstract] [Full Text] [Related]
9. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ. Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079 [Abstract] [Full Text] [Related]
10. Milrinone in meningococcal sepsis. Rich N, West N, McMaster P, Alexander J. Pediatr Crit Care Med; 2003 Jul; 4(3):394-5. PubMed ID: 12840611 [No Abstract] [Full Text] [Related]
11. [Cardiotonic drugs in acute heart failure]. Richard C. Rev Prat; 1989 May 25; 39(16):1422-9. PubMed ID: 2740795 [No Abstract] [Full Text] [Related]
12. Proper use of phosphodiesterase inhibitors according to the situations. Tanwiphongtrakun T, Inoue S, Furuya H. Acta Anaesthesiol Taiwan; 2006 Sep 25; 44(3):183-5. PubMed ID: 17037008 [Abstract] [Full Text] [Related]
13. Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use? Simkova V, Radermacher P, Barth E. Crit Care; 2007 Sep 25; 11(3):139. PubMed ID: 17572916 [Abstract] [Full Text] [Related]
14. [Non-digitalis and non-beta-mimetic tonicardiac agents]. Delaye J, Didier B. Rev Prat; 1986 Oct 01; 36(43):2521-4. PubMed ID: 3787147 [No Abstract] [Full Text] [Related]
15. Pharmacologic intervention for acute low cardiac output. Marchetti A, Wechsler AS. Adv Card Surg; 1996 Oct 01; 7():31-64. PubMed ID: 8775182 [No Abstract] [Full Text] [Related]
16. [Intravenous milrinone in the treatment of pediatric heart failure]. Han XZ, Sun Y. Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb 01; 9(1):73-4. PubMed ID: 17306085 [No Abstract] [Full Text] [Related]
17. Enoximone in intensive care. Proceedings of a symposium. Brussels, Belgium, 21st March 1988. Br J Clin Pract Suppl; 1988 Dec 01; 64():1-87. PubMed ID: 2978495 [No Abstract] [Full Text] [Related]